Baker Bros Advisors Lp decreased Chemocentryx Inc. (CCXI) stake by 50% reported in 2018Q4 SEC filing. Baker Bros Advisors Lp sold 207,000 shares as Chemocentryx Inc. (CCXI)’s stock rose 6.99%. The Baker Bros Advisors Lp holds 207,029 shares with $2.26 million value, down from 414,029 last quarter. Chemocentryx Inc. now has $706.44M valuation. The stock increased 1.93% or $0.23 during the last trading session, reaching $12.17. About 190,702 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 15, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/03/2018 ChemoCentryx 4Q EPS 80c; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress
Dekabank Deutsche Girozentrale increased Bunge Limited (BG) stake by 155.71% reported in 2018Q4 SEC filing. Dekabank Deutsche Girozentrale acquired 54,427 shares as Bunge Limited (BG)’s stock declined 9.93%. The Dekabank Deutsche Girozentrale holds 89,380 shares with $4.79 million value, up from 34,953 last quarter. Bunge Limited now has $7.58B valuation. The stock increased 1.77% or $0.93 during the last trading session, reaching $53.58. About 444,808 shares traded. Bunge Limited (NYSE:BG) has declined 30.49% since May 15, 2018 and is downtrending. It has underperformed by 34.86% the S&P500. Some Historical BG News: 05/03/2018 – CONTINENTAL GRAIN IS EXPECTED ON MONDAY TO SECURE APPROVAL FROM U.S. ANTITRUST REGULATORS TO PURCHASE MORE STOCK – WSJ, CITING; 02/05/2018 – Bunge Canada: Closing Canola Prices – May 2; 02/05/2018 – CHINA `VERY DELIBERATELY’ NOT BUYING U.S SOYBEANS: BUNGE CEO; 21/03/2018 – Bunge Canada: Closing Canola Prices – Mar 21; 02/05/2018 – BUNGE CEO SCHRODER MAKES COMMENTS ON SOY IN PHONE INTERVIEW; 02/05/2018 – BUNGE SEES WEIGHTED CRUSH MARGIN AVERAGE $30-$40; 09/03/2018 – Potential Deal Derailed Amid Concern Over Antitrust Pushback; 05/03/2018 – COFCO INTERNATIONAL SAYSSELINA YANG, FORMERLY GLOBAL HEAD OF GRAINS AND OILSEEDS, NAMED COO; 18/04/2018 – Bunge Canada: Closing Canola Prices – Apr 18; 16/05/2018 – BUNGE: CHANCE FOR HIGHER ELEVATOR MARGINS ON U.S.-CHINA SPAT
Since January 7, 2019, it had 0 insider purchases, and 5 selling transactions for $1.38 million activity. Shares for $242,370 were sold by Schall Thomas J. on Monday, January 7. Cappel Markus J. sold 13,203 shares worth $158,790. The insider KANAYA SUSAN M sold 37,893 shares worth $457,747.
Among 4 analysts covering ChemoCentryx (NASDAQ:CCXI), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ChemoCentryx had 4 analyst reports since February 11, 2019 according to SRatingsIntel. The rating was upgraded by FBR Capital on Wednesday, March 27 to “Buy”. The rating was initiated by Leerink Swann with “Buy” on Thursday, February 14. H.C. Wainwright maintained ChemoCentryx, Inc. (NASDAQ:CCXI) on Tuesday, March 12 with “Buy” rating.
Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 8. They expect $-0.26 EPS, down 85.71% or $0.12 from last year’s $-0.14 per share. After $-0.23 actual EPS reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 13.04% negative EPS growth.
Baker Bros Advisors Lp increased Ra Pharmaceuticals Inc. stake by 645,161 shares to 823,113 valued at $14.98 million in 2018Q4. It also upped Neurocrine Biosciences Inc. (Prn) stake by 43.27 million shares and now owns 53.27M shares. Zymeworks Inc. was raised too.
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights – GlobeNewswire” on May 06, 2019, also Nasdaq.com with their article: “ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates – Nasdaq” published on May 06, 2019, Seekingalpha.com published: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” on May 06, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners â€” New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” published on April 16, 2019 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: March 12, 2019.
Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It turned negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. D E Shaw And holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 214,899 shares. Bnp Paribas Arbitrage has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). California State Teachers Retirement System holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 35,245 shares. Adams Diversified Equity Fund invested in 0.03% or 38,600 shares. Legal And General Grp Incorporated Plc holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 3,615 shares. Rhumbline Advisers accumulated 30,596 shares or 0% of the stock. Fosun Intl, Hong Kong-based fund reported 100,976 shares. Tiaa Cref Invest Management Ltd Company owns 311,491 shares. Nantahala Mngmt Limited Company has 623,338 shares. Smith Asset Grp Limited Partnership reported 22,897 shares. Franklin Res has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). Panagora Asset Mgmt reported 0.02% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). 487,355 are owned by State Street Corp. Strs Ohio holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 55,800 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv Mngmt Corporation has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI).
More notable recent Bunge Limited (NYSE:BG) news were published by: Benzinga.com which released: “Bunge Limited (NYSE:BG) – Q1 Earnings Outlook For Bunge – Benzinga” on May 07, 2019, also Seekingalpha.com with their article: “Bunge Q1 2019 Earnings Preview – Seeking Alpha” published on May 07, 2019, Seekingalpha.com published: “Bunge Limited 2019 Q1 – Results – Earnings Call Slides – Seeking Alpha” on May 08, 2019. More interesting news about Bunge Limited (NYSE:BG) were released by: Benzinga.com and their article: “10 Stocks To Watch For May 8, 2019 – Benzinga” published on May 08, 2019 as well as Seekingalpha.com‘s news article titled: “Bunge appoints Heckman as fulltime CEO – Seeking Alpha” with publication date: April 25, 2019.
Dekabank Deutsche Girozentrale decreased Taiwan Semiconductor Mfg Ltd (NYSE:TSM) stake by 2.04M shares to 179,750 valued at $6.61M in 2018Q4. It also reduced Landstar Sys Inc (NASDAQ:LSTR) stake by 27,200 shares and now owns 3,800 shares. Global Pmts Inc (NYSE:GPN) was reduced too.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.